share_log

GoodRx Shares Soar Nearly 10% As New Partnership With Kroger Promises Big Savings

GoodRx Shares Soar Nearly 10% As New Partnership With Kroger Promises Big Savings

由於與克羅格的新合作伙伴關係有望節省大量資金,GoodRx股價飆升了近10%
Benzinga ·  05/15 14:40

GoodRx Holdings Inc. (GDRX) shares surged nearly 10% Wednesday afternoon following the announcement of a new direct contracting agreement with Kroger Co. (NYSE:KR).

在宣佈與克羅格公司簽訂新的直接合同協議後,GoodRx控股公司(GDRX)股價週三下午飆升了近10%。(紐約證券交易所代碼:KR)。

What To Know: The agreement, spanning over 2,200 Kroger Family Pharmacy locations nationwide, aims to enhance prescription pricing accessibility and affordability for consumers.

須知:該協議涵蓋全國2,200多個克羅格家庭藥房,旨在提高消費者的處方定價可及性和可負擔性。

GoodRx and Kroger said the companies reached a mutually beneficial agreement that enables them to deliver lower prices directly to patients. GoodRx noted that it had been focused on transforming how it delivers value to retail pharmacies in recent years.

GoodRx和克羅格表示,兩家公司達成了一項互惠互利的協議,使他們能夠直接向患者提供更低的價格。GoodRx指出,近年來,它一直專注於改變其爲零售藥房提供價值的方式。

"We are excited to renew our relationship with Kroger. Kroger has been a valuable participant in the GoodRx marketplace over the years and an innovator in healthcare, nutrition and wellness. We've leveraged our direct contracting model to reach an agreement that we believe supports Kroger's business goals and helps patients get the prescriptions they need at affordable prices," said Scott Wagner, interim CEO of GoodRx.

“我們很高興恢復與克羅格的關係。多年來,克羅格一直是GoodRx市場的重要參與者,也是醫療保健、營養和保健領域的創新者。我們利用直接簽約模式達成了一項協議,我們認爲該協議支持克羅格的業務目標,並幫助患者以可承受的價格獲得所需的處方。” GoodRx臨時首席執行官斯科特·瓦格納說。

As a result of the agreement, patients will be able to present a GoodRx coupon at Kroger Pharmacies to receive more savings on the expected patient price for most generics, beginning on June 1.

根據該協議,從6月1日開始,患者將能夠在克羅格藥房出示GoodRx優惠券,以便在大多數仿製藥的預期患者價格上獲得更多優惠。

GoodRx remains steadfast in its commitment to providing transparent and affordable prescription pricing. The direct-contracting agreement with Kroger promises nearly 50% more savings on most generics.

GoodRx仍然堅定不移地致力於提供透明且負擔得起的處方價格。與克羅格的直接合同協議承諾在大多數仿製藥上節省近50%。

GoodRX shares were up 9.43% at $7.29 at the time of writing, according to Benzinga Pro.

根據Benzinga Pro的數據,在撰寫本文時,GoodRx股價上漲9.43%,至7.29美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論